Your browser doesn't support javascript.
loading
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Rossi, Davide; Terzi-di-Bergamo, Lodovico; De Paoli, Lorenzo; Cerri, Michaela; Ghilardi, Guido; Chiarenza, Annalisa; Bulian, Pietro; Visco, Carlo; Mauro, Francesca R; Morabito, Fortunato; Cortelezzi, Agostino; Zaja, Francesco; Forconi, Francesco; Laurenti, Luca; Del Giudice, Ilaria; Gentile, Massimo; Vincelli, Iolanda; Motta, Marina; Coscia, Marta; Rigolin, Gian Matteo; Tedeschi, Alessandra; Neri, Antonino; Marasca, Roberto; Perbellini, Omar; Moreno, Carol; Del Poeta, Giovanni; Massaia, Massimo; Zinzani, Pier Luigi; Montillo, Marco; Cuneo, Antonio; Gattei, Valter; Foà, Robin; Gaidano, Gianluca.
  • Rossi D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Terzi-di-Bergamo L; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • De Paoli L; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Cerri M; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Ghilardi G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Chiarenza A; Hematology, Department of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy;
  • Bulian P; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy;
  • Visco C; Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy;
  • Mauro FR; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
  • Morabito F; Hematology Unit, Department of Onco-Hematology, Hospital of Cosenza, Cosenza, Italy;
  • Cortelezzi A; Department of Hematology Oncology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy;
  • Zaja F; Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" Department of Experimental and Clinical Medical Sciences (DISM), Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy;
  • Forconi F; Cancer Sciences Unit, Southampton Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom; Division of Hematology, University of Siena, Siena, Italy;
  • Laurenti L; Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy;
  • Del Giudice I; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
  • Gentile M; Hematology Unit, Department of Onco-Hematology, Hospital of Cosenza, Cosenza, Italy;
  • Vincelli I; Hematology Unit, Hospital of Reggio Calabria, Reggio Calabria, Italy;
  • Motta M; Department of Hematology, Spedali Civili, Brescia, Italy;
  • Coscia M; Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza and University of Turin, Turin, Italy;
  • Rigolin GM; Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy;
  • Tedeschi A; Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy;
  • Neri A; Department of Clinical Sciences and Community Health, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy;
  • Marasca R; Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy;
  • Perbellini O; Section of Hematology, Department of Medicine, University of Verona, Verona, Italy;
  • Moreno C; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;
  • Del Poeta G; Department of Hematology, Tor Vergata University, Rome, Italy;
  • Massaia M; Hematology and Cell Therapy Unit, Ospedale Mauriziano and University of Turin, Turin, Italy; and.
  • Zinzani PL; Institute of Hematology 'L. e A. Seràgnoli', University of Bologna, Bologna, Italy.
  • Montillo M; Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy;
  • Cuneo A; Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy;
  • Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy;
  • Foà R; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
  • Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
Blood ; 126(16): 1921-4, 2015 Oct 15.
Article en En | MEDLINE | ID: mdl-26276669
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 11 / Cromosomas Humanos Par 17 / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Deleción Cromosómica / Síndrome de Smith-Magenis Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 11 / Cromosomas Humanos Par 17 / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Deleción Cromosómica / Síndrome de Smith-Magenis Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article